Companies › ATYR

ATYR PHARMA INC (ATYR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001339970 · EDGAR filings · Updated 2026-07-27

ATYR PHARMA INC (ATYR) has reported institutional ownership of 57.2%, with 111 institutional managers holding positions valued at $43.7M per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-08 — SCHEDULE 13G/A filed
• 2026-06-08 — Current report (8-K) filed
• 2026-06-05 — SCHEDULE 13G/A filed
• 2026-06-01 — Current report (8-K) filed
• 2026-05-28 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ATYR PHARMA INC has 111 institutional holders and institutional ownership of 57.2%.

Insider activity

Insiders reported 8 transactions (2 buys, 3 sells) across 4 reporting insiders, with a net reported value of $906.4K.

Data flags from SEC filings

Related companies

PMV PHARMACEUTICALS INC (PMVP) · Oramed Pharmaceuticals Inc (ORMP) · CARTESIAN THERAPEUTICS INC (RNAC) · Adicet Bio Inc (ACET) · SATELLOS BIOSCIENCE INC (MSLE) · Rallybio Corp (RLYB)